Interpace Biosciences Quick Ratio 2010-2023 | IDXG
Interpace Biosciences Quick Ratio Historical Data | |||
---|---|---|---|
Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
2023-12-31 | $0.00B | $0.02B | 0.00 |
2023-09-30 | $0.00B | $0.01B | 0.00 |
2023-06-30 | $0.00B | $0.01B | 0.00 |
2023-03-31 | $0.00B | $0.01B | 0.00 |
2022-12-31 | $0.00B | $0.01B | 0.00 |
2022-09-30 | $0.00B | $0.02B | 0.00 |
2022-06-30 | $0.00B | $0.02B | 0.00 |
2022-03-31 | $0.00B | $0.02B | 0.00 |
2021-12-31 | $0.00B | $0.02B | 0.00 |
2021-09-30 | $0.00B | $0.02B | 0.00 |
2021-06-30 | $0.00B | $0.02B | 0.00 |
2021-03-31 | $0.00B | $0.02B | 0.00 |
2020-12-31 | $0.00B | $0.02B | 0.00 |
2020-09-30 | $0.00B | $0.02B | 0.00 |
2020-06-30 | $0.00B | $0.02B | 0.00 |
2020-03-31 | $0.00B | $0.02B | 0.00 |
2019-12-31 | $0.00B | $0.02B | 0.00 |
2019-09-30 | $0.00B | $0.02B | 0.00 |
2019-06-30 | $0.00B | $0.01B | 0.00 |
2019-03-31 | $0.00B | $0.01B | 0.00 |
2018-12-31 | $0.00B | $0.01B | 0.00 |
2018-09-30 | $0.00B | $0.01B | 0.00 |
2018-06-30 | $0.00B | $0.01B | 0.00 |
2018-03-31 | $0.00B | $0.01B | 0.00 |
2017-12-31 | $0.00B | $0.01B | 0.00 |
2017-09-30 | $0.00B | $0.01B | 0.00 |
2017-06-30 | $0.00B | $0.01B | 0.00 |
2017-03-31 | $0.00B | $0.01B | 0.00 |
2016-12-31 | $0.00B | $0.02B | 0.00 |
2016-09-30 | $0.00B | $0.02B | 0.00 |
2016-06-30 | $0.00B | $0.02B | 0.00 |
2016-03-31 | $0.00B | $0.02B | 0.00 |
2015-12-31 | $0.00B | $0.02B | 0.00 |
2015-09-30 | $0.00B | $0.03B | 0.00 |
2015-06-30 | $0.00B | $0.04B | 0.00 |
2015-03-31 | $0.00B | $0.03B | 0.00 |
2014-12-31 | $0.00B | $0.03B | 0.00 |
2014-09-30 | $0.00B | $0.03B | 0.00 |
2014-06-30 | $0.00B | $0.03B | 0.00 |
2014-03-31 | $0.00B | $0.03B | 0.00 |
2013-12-31 | $0.00B | $0.03B | 0.00 |
2013-09-30 | $0.00B | $0.03B | 0.00 |
2013-06-30 | $0.00B | $0.03B | 0.00 |
2013-03-31 | $0.00B | $0.04B | 0.00 |
2012-12-31 | $0.00B | $0.04B | 0.00 |
2012-09-30 | $0.00B | $0.04B | 0.00 |
2012-06-30 | $0.00B | $0.04B | 0.00 |
2012-03-31 | $0.00B | $0.04B | 0.00 |
2011-12-31 | $0.00B | $0.05B | 0.00 |
2011-09-30 | $0.00B | $0.05B | 0.00 |
2011-06-30 | $0.00B | $0.04B | 0.00 |
2011-03-31 | $0.00B | $0.04B | 0.00 |
2010-12-31 | $0.00B | $0.04B | 0.00 |
2010-09-30 | $0.00B | $0.03B | 0.00 |
2010-06-30 | $0.00B | $0.03B | 0.00 |
2010-03-31 | $0.00B | $0.02B | 0.00 |
2009-12-31 | $0.00B | $0.03B | 0.00 |
2009-09-30 | $0.00B | $0.02B | 0.00 |
2009-06-30 | $0.00B | $0.02B | 0.00 |
2009-03-31 | $0.00B | $0.02B | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.006B | $0.040B |
Interpace Biosciences Inc. is enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services include molecular diagnostic tests, bioinformatics, and pathology services. Pharma services provide pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. Interpace Biosciences Inc., formerly known as INTERPACE DIAGN, is based in PARSIPPANY, NJ. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $123.512B | 15.50 |
Cencora (COR) | United States | $47.702B | 19.04 |
ICON (ICLR) | Ireland | $23.778B | 23.45 |
DiDi Global (DIDIY) | China | $21.472B | 0.00 |
Avantor (AVTR) | United States | $16.347B | 22.52 |
Viatris (VTRS) | United States | $13.496B | 3.85 |
CochLear (CHEOY) | $13.392B | 0.00 | |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.462B | 0.00 |
Revvity (RVTY) | United States | $12.459B | 21.69 |
Charles River Laboratories (CRL) | United States | $11.682B | 21.29 |
Medpace Holdings (MEDP) | United States | $11.526B | 41.89 |
Solventum (SOLV) | United States | $10.730B | 0.00 |
Natera (NTRA) | United States | $10.298B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
HealthEquity (HQY) | United States | $6.940B | 51.85 |
Bausch + Lomb (BLCO) | Canada | $5.145B | 19.78 |
Doximity (DOCS) | United States | $4.595B | 34.21 |
Organon (OGN) | United States | $4.555B | 4.41 |
PACS (PACS) | United States | $3.551B | 0.00 |
Progyny (PGNY) | United States | $3.143B | 52.74 |
Sotera Health (SHC) | United States | $3.100B | 15.21 |
Surgery Partners (SGRY) | United States | $3.017B | 28.03 |
Life Times (LTH) | United States | $2.756B | 30.46 |
GoodRx Holdings (GDRX) | United States | $2.643B | 133.80 |
Premier (PINC) | United States | $2.538B | 9.29 |
Agilon Health (AGL) | United States | $2.244B | 0.00 |
Teladoc Health (TDOC) | United States | $2.198B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.158B | 6.98 |
BrightSpring Health Services (BTSG) | United States | $1.799B | 0.00 |
Agiliti (AGTI) | United States | $1.366B | 22.31 |
Establishment Labs Holdings (ESTA) | $1.301B | 0.00 | |
NovoCure (NVCR) | Jersey | $1.301B | 0.00 |
Alignment Healthcare (ALHC) | United States | $0.983B | 0.00 |
Pediatrix Medical (MD) | United States | $0.759B | 7.85 |
Embecta (EMBC) | United States | $0.611B | 4.04 |
InnovAge Holding (INNV) | United States | $0.537B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.519B | 0.00 |
Enhabit (EHAB) | United States | $0.514B | 46.59 |
Auna S.A (AUNA) | Luxembourg | $0.503B | 0.00 |
CareDx (CDNA) | United States | $0.430B | 0.00 |
MultiPlan (MPLN) | United States | $0.419B | 0.00 |
Beauty Health (SKIN) | United States | $0.404B | 0.00 |
LifeMD (LFMD) | United States | $0.392B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.388B | 0.00 |
DocGo (DCGO) | United States | $0.372B | 59.50 |
Sera Prognostics (SERA) | United States | $0.316B | 0.00 |
ModivCare (MODV) | United States | $0.302B | 4.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.263B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.251B | 0.00 |
Sharecare (SHCR) | United States | $0.235B | 0.00 |
Biodesix (BDSX) | United States | $0.121B | 0.00 |
So-Young (SY) | China | $0.115B | 38.67 |
Oncology Institute (TOI) | United States | $0.088B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.064B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
NeueHealth (NEUE) | United States | $0.048B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
Nutex Health (NUTX) | United States | $0.035B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
DermTech (DMTK) | United States | $0.022B | 0.00 |
OncoCyte (OCX) | United States | $0.021B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
OpGen (OPGN) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.006B | 0.00 |
Assure Holdings (IONM) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |